PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UFPT vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UFPT and ABBV is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

UFPT vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-19.10%
3.28%
UFPT
ABBV

Key characteristics

Sharpe Ratio

UFPT:

1.07

ABBV:

0.48

Sortino Ratio

UFPT:

1.78

ABBV:

0.75

Omega Ratio

UFPT:

1.22

ABBV:

1.12

Calmar Ratio

UFPT:

1.69

ABBV:

0.60

Martin Ratio

UFPT:

4.37

ABBV:

1.50

Ulcer Index

UFPT:

12.91%

ABBV:

7.66%

Daily Std Dev

UFPT:

52.55%

ABBV:

23.77%

Max Drawdown

UFPT:

-88.53%

ABBV:

-45.09%

Current Drawdown

UFPT:

-26.85%

ABBV:

-14.00%

Fundamentals

Market Cap

UFPT:

$1.96B

ABBV:

$302.80B

EPS

UFPT:

$6.98

ABBV:

$2.86

PE Ratio

UFPT:

36.50

ABBV:

59.91

PEG Ratio

UFPT:

0.00

ABBV:

0.40

Total Revenue (TTM)

UFPT:

$360.35M

ABBV:

$41.23B

Gross Profit (TTM)

UFPT:

$104.64M

ABBV:

$30.76B

EBITDA (TTM)

UFPT:

$70.05M

ABBV:

$17.62B

Returns By Period

In the year-to-date period, UFPT achieves a 7.23% return, which is significantly higher than ABBV's -1.33% return. Over the past 10 years, UFPT has outperformed ABBV with an annualized return of 27.29%, while ABBV has yielded a comparatively lower 15.13% annualized return.


UFPT

YTD

7.23%

1M

3.47%

6M

-19.10%

1Y

61.71%

5Y*

41.12%

10Y*

27.29%

ABBV

YTD

-1.33%

1M

-0.02%

6M

3.28%

1Y

11.11%

5Y*

19.56%

10Y*

15.13%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UFPT vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UFPT
The Risk-Adjusted Performance Rank of UFPT is 8080
Overall Rank
The Sharpe Ratio Rank of UFPT is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of UFPT is 7878
Sortino Ratio Rank
The Omega Ratio Rank of UFPT is 7474
Omega Ratio Rank
The Calmar Ratio Rank of UFPT is 8888
Calmar Ratio Rank
The Martin Ratio Rank of UFPT is 7979
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6363
Overall Rank
The Sharpe Ratio Rank of ABBV is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5555
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 5858
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 7272
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6464
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UFPT vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for UFPT, currently valued at 1.07, compared to the broader market-2.000.002.004.001.070.48
The chart of Sortino ratio for UFPT, currently valued at 1.78, compared to the broader market-4.00-2.000.002.004.001.780.75
The chart of Omega ratio for UFPT, currently valued at 1.22, compared to the broader market0.501.001.502.001.221.12
The chart of Calmar ratio for UFPT, currently valued at 1.69, compared to the broader market0.002.004.006.001.690.60
The chart of Martin ratio for UFPT, currently valued at 4.37, compared to the broader market-10.000.0010.0020.0030.004.371.50
UFPT
ABBV

The current UFPT Sharpe Ratio is 1.07, which is higher than the ABBV Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of UFPT and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
1.07
0.48
UFPT
ABBV

Dividends

UFPT vs. ABBV - Dividend Comparison

UFPT has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.62%.


TTM20242023202220212020201920182017201620152014
UFPT
UFP Technologies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ABBV
AbbVie Inc.
3.62%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

UFPT vs. ABBV - Drawdown Comparison

The maximum UFPT drawdown since its inception was -88.53%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for UFPT and ABBV. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-26.85%
-14.00%
UFPT
ABBV

Volatility

UFPT vs. ABBV - Volatility Comparison

UFP Technologies, Inc. (UFPT) has a higher volatility of 12.13% compared to AbbVie Inc. (ABBV) at 5.71%. This indicates that UFPT's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
12.13%
5.71%
UFPT
ABBV

Financials

UFPT vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between UFP Technologies, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab